Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, B.-H. | - |
dc.contributor.author | Song, Y.-S. | - |
dc.contributor.author | Park, J. | - |
dc.contributor.author | Ryu, J.-C. | - |
dc.date.accessioned | 2024-01-21T22:11:00Z | - |
dc.date.available | 2024-01-21T22:11:00Z | - |
dc.date.created | 2021-09-02 | - |
dc.date.issued | 1994-01 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/145912 | - |
dc.description.abstract | The metabolism and pharmacokinetics of a mixed disulfide S-(N,N-diethyldithiocarbamoyl)-N-acetyl-L-cysteine (AC-DDTC) were studied in rats. Two metabolites of AC-DDTC following iv and po administration were identified in plasma and liver by HPLC and GC, namely N,N-diethyldithiocarbamate (DDTC) and the methyl ester of DDTC (Me-DDTC). AC-DDTC was very unstable in vivo and could not be detected neither in plasma nor in urine. Pharmacokinetic parameters of DDTC following intravenous administration of AC-DDTC (20 mg/kg) were calculated. DDTC has a low affinity to rat tissue and the total body clearance was 9.0±3.4 ml/min/kg. The mean residence time (MRT) was 111.5±16.3 min. After oral administration of 20 mg/kg AC-DDTC, maximal plasma concentration (Cmax) was 3.8±0.2 nmol/ml and the bioavailability was 7.04%. Cmax for DDTC at a dose of 120 mg/kg. AC-DDTC was 40.1±2.2 nmol/ml. MRT was 47.1±2.8 min at a dose of 20 mg/kg and 110.5±6.0 min at 120 mg/kg. ? 1994, The Pharmaceutical Society of Korea. All rights reserved. | - |
dc.language | English | - |
dc.subject | 5 (n,n diethyldithiocarbamoyl) n acetylcysteine | - |
dc.subject | unclassified drug | - |
dc.subject | animal experiment | - |
dc.subject | article | - |
dc.subject | controlled study | - |
dc.subject | drug blood level | - |
dc.subject | drug metabolism | - |
dc.subject | drug tissue level | - |
dc.subject | drug urine level | - |
dc.subject | gas chromatography | - |
dc.subject | high performance liquid chromatography | - |
dc.subject | intravenous drug administration | - |
dc.subject | liver | - |
dc.subject | nonhuman | - |
dc.subject | oral drug administration | - |
dc.subject | rat | - |
dc.subject | Acetylcysteine | - |
dc.subject | Animal | - |
dc.subject | Antimutagenic Agents | - |
dc.subject | Area Under Curve | - |
dc.subject | Chromatography, High Pressure Liquid | - |
dc.subject | Indicators and Reagents | - |
dc.subject | Male | - |
dc.subject | Rats | - |
dc.subject | Rats, Sprague-Dawley | - |
dc.subject | Support, Non-U.S. Gov&apos | - |
dc.subject | t | - |
dc.title | Metabolism and pharmacokinetics of S-(N,N-diethyldithiocarbamoyl)-N-acetyl-L-cysteine in rats | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/BF02979120 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | Archives of Pharmacal Research, v.17, no.6, pp.428 - 433 | - |
dc.citation.title | Archives of Pharmacal Research | - |
dc.citation.volume | 17 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 428 | - |
dc.citation.endPage | 433 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.scopusid | 2-s2.0-0028673661 | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | 5 (n,n diethyldithiocarbamoyl) n acetylcysteine | - |
dc.subject.keywordPlus | unclassified drug | - |
dc.subject.keywordPlus | animal experiment | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | drug blood level | - |
dc.subject.keywordPlus | drug metabolism | - |
dc.subject.keywordPlus | drug tissue level | - |
dc.subject.keywordPlus | drug urine level | - |
dc.subject.keywordPlus | gas chromatography | - |
dc.subject.keywordPlus | high performance liquid chromatography | - |
dc.subject.keywordPlus | intravenous drug administration | - |
dc.subject.keywordPlus | liver | - |
dc.subject.keywordPlus | nonhuman | - |
dc.subject.keywordPlus | oral drug administration | - |
dc.subject.keywordPlus | rat | - |
dc.subject.keywordPlus | Acetylcysteine | - |
dc.subject.keywordPlus | Animal | - |
dc.subject.keywordPlus | Antimutagenic Agents | - |
dc.subject.keywordPlus | Area Under Curve | - |
dc.subject.keywordPlus | Chromatography, High Pressure Liquid | - |
dc.subject.keywordPlus | Indicators and Reagents | - |
dc.subject.keywordPlus | Male | - |
dc.subject.keywordPlus | Rats | - |
dc.subject.keywordPlus | Rats, Sprague-Dawley | - |
dc.subject.keywordPlus | Support, Non-U.S. Gov&apos | - |
dc.subject.keywordPlus | t | - |
dc.subject.keywordAuthor | Disulfiram | - |
dc.subject.keywordAuthor | Gas Chromatography | - |
dc.subject.keywordAuthor | High Performance Liquid Chromatography | - |
dc.subject.keywordAuthor | Metabolism | - |
dc.subject.keywordAuthor | Mixed Disulfide | - |
dc.subject.keywordAuthor | Pharmacokinetics | - |
dc.subject.keywordAuthor | S-(N,N-diethyldithiocarbamoyl)-N-acetyl-L-cysteine | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.